fIIa and fXa are two of the main targets of antithrombin, a serine proteases inhibitor that plays a major role in the regulation of blood clotting. The formation of ternary complexes between such molecules and glycosaminoglycans, as heparin, is the main path for inhibiting those enzymes, which may occur through two distinct mechanisms of action. While these serine proteases present distinct susceptibilities to these paths, in which fIIa demands an interaction with heparin, neither the molecular basis of this differential inhibition nor the role of fIIa glycosylation on this process is fully understood. Thus, the present work evaluated through molecular dynamics simulations the effects of glycosylation on fIIa and the consequences of heparin binding to both proteases function and dynamics. Based on the obtained data, fIIa N-linked glycan promoted an increase in the active site pocket size by stabilizing regions that encircle it, while heparin binding was observed to reverse such an effect. Additionally, heparin orientation observed on the surface of fIIa, but not fXa, allows a linear long-chain heparin binding to antithrombin in ternary complexes. Finally, the enzymes catalytic triad organization was disrupted due to a strong glycosaminoglycan binding to the proteases exosite 2. Such data support an atomiclevel explanation for the higher inhibition constant of the antithrombin-heparin complex over fIIa than fXa, as well as for the different susceptibilities of those enzymes for antithrombin mechanisms of action.
Introduction
Blood coagulation involves the sequential activation of serine proteases, which culminates in the generation of thrombin (fIIa) and a subsequent conversion of fibrinogen into insoluble fibrin (Furie and Furie 1988) . Several studies point out that, among such reactions, those related to factor X activation into factor Xa (fXa) by the intrinsic tenase complex is the rate-limiting step for fIIa generation and, consequently, fibrin production (Lawson et al. 1994; Rand et al. 1996) . The major inhibitor of plasma proteinases, antithrombin (AT), a member of serine proteinase inhibitors (serpin) family, shows as its two main targets both fIIa and fXa (Rau et al. 2007) . AT mechanism of action includes the formation of highly stable equimolar complexes with such enzymes, which are possibly inactivated by structural deformation (Huntington et al. 2000) . Additionally, sulfated glycosaminoglycans (GAG), as therapeutic heparin or endothelial heparan sulfate proteoglycans, are known to accelerate such inactivating reactions upon AT binding to a minimum sequence-specific pentasaccharide site (Olson et al. 2004) . GAGs are a group of sulfated polysaccharides composed of repeating disaccharide units, varying in their glycosidic linkage geometries and monosaccharide constitution (Gandhi and Mancera 2008) . Heparin, specifically, consists of repeating units of 1 → 4 linked glucosamine and iduronic or glucuronic acid residues, with varying sulfation pattern, depending on the polysaccharide source (Nader et al. 2001) .
It is well established that heparin can exert its effect on AT-proteases inhibition rate through [1] a conformational activation mechanism, in which the sequence-specific pentasaccharide fragment binds uniquely to AT, altering its conformation to improve its reactivity with coagulation proteases, or [2] a bridge (template) mechanism, in which long-chain heparins concomitantly bind both serpin and protease (Gettins 2002; Olson et al. 2004 ). Regarding such mechanisms of action, while the specific heparin pentasaccharide alone is sufficient to enhance the rate of inactivation over fXa (Choay et al. 1983) , as observed from its corresponding X-ray structure (Johnson et al. 2006) , at least 13 additional saccharide residues are required for a significant heparin-mediated inhibition of fIIa (Laurent et al. 1978; Oosta et al. 1981; Lane et al. 1984) . In this scenario, while an AT-mediated thrombin inhibition demands protease-heparin interaction, as observed through X-ray crystallography (Li et al. 2004) , only under certain conditions is fXa capable of binding such GAG in a bridging complex (Rezaie 1998; Rezaie and Olson 2000) . For both enzymes, such protein-heparin interaction is described to occur through their exosite 2-composing amino acid residues (Sheehan and Sadler 1994; Rezaie 2000) . In addition, GAGs binding to both proteases has been shown to induce conformational changes in their active sites (Fredenburgh et al. 1997; O'Brien et al. 2003) . In spite of such an amount of information regarding fIIa and fXa inhibition, a structural determination, at atomic level, of the possible differences on such enzymes binding to heparin and the consequences of such interaction over their dynamics is still absent. Considering the highly flexible nature of the carbohydrate chains composing such systems, including heparin oligosaccharides, molecular dynamics (MD) simulations emerge as a promising tool for describing such complexes considering both spatial and temporal properties, thus accounting for most of its containing structural and dynamical variables, as solvation and thrombin N-glycosylation (Nilsson et al. 1983) .
In this context, the present work intends to evaluate heparin binding to the exosite 2 of fIIa and fXa, as well as the mutual influence of this interaction between polysaccharide and enzymes, through a series of MD simulations. Additionally, under the evaluated conditions, thrombin was studied comparatively in its non-glycosylated and glycosylated ( physiological) forms. Such data were accordingly compared with those of previous biochemical, mutagenesis-derived analysis and X-ray crystallography structures, as well as reinforced by dynamic network and principal component analyses. Based on these data, insights into the formation of ternary complexes involving the GAG, AT and two of the main coagulation cascade serine proteases could be obtained, supporting the proposal of an atomic model for the dynamics of heparin and other endogenous GAGs when bound to such enzymes.
Results

Systems preparation
In order to assess the effects of heparin interaction with the evaluated serine proteases, each enzyme was studied both unbound and bound to the GAG. fIIa was considered in its physiological, glycosylated form and in a non-glycosylated state, which was studied as a control to evaluate the effects of glycosylation on its structure and flexibility. In addition, fXa was assessed in systems both including and not including Ca
2+
, as the presence of such divalent cation allows fXa to bind heparin in a bridging complex with AT (Rezaie 1998; Rezaie and Olson 2000) . Thus, eight systems were studied, comprising non-glycosylated fIIa, glycosylated fIIa, fXa in a Ca 2+ -absent system and fXa in a system with Ca 2+ , each unbound and bound to heparin. The studied enzymes show very different non-catalytic domains, both in terms of size (Supplementary data, Figure S1A ) and function, especially regarding fXa light-chain γ-carboxyglutamic acid (GLA) domain and its calcium-dependent interaction with anionic phospholipid surfaces (Furie and Furie 1988) . As no interaction of heparin with these regions was observed, no data were obtained from the simulations for either fIIa or fXa light chains. Of interest to the present work, while the catalytic domain of thrombin and fXa presents only about 40% of sequence identity (Supplementary data, Figure S1B ), their tertiary structure is quite similar, showing RMSD < 3 Å (Supplementary data, Figure S1C ), and the exosite for heparin interaction is located in the same 3D region (Supplementary data, Figure S1D ). In view of that, the heparin orientation on the surface of thrombin in previous X-ray structures (Li et al. 2004; Carter et al. 2005) was also employed as a starting structure for fXa. The structures and parameters for such heparin oligosaccharide, as well as for thrombin N-linked glycan, were obtained from previous publications on heparin-glycoprotein complexes .
Thrombin glycosylation
The effects of N-glycans on thrombin were initially evaluated by its heavy-chain root mean square fluctuation (RMSF), from which it may be observed that the protein global flexibility is mostly unchanged due to glycosylation ( Figure 1D) . Still, the Asn60G-linked oligosaccharide appeared to be capable of reducing the flexibility of four regions that encircle the enzyme active site ( Figure 1B-D) , including the 60-60G region, where the N-glycan is attached. As the entrance to thrombin active site has been described to be partially occluded by the 60-60G loop in X-ray structures (Bode et al. 1992) , we evaluated whether such flexibility difference would also influence the active site pocket size. Thus, based on CASTp measurement of cavity and pocket sizes (Dundas et al. 2006) , it was observed that glycosylation, while stabilizing the motion of these regions, is capable of increasing the active site pocket size (Table I , P ≤ 0.05). Such modifications were accompanied by alterations in the interaction of those regions with their surroundings, including a decreased interaction with the solvent (except for the 165-180 loop) and an increased interaction with the remaining protein moiety (Supplementary data, Table S1 ). In addition, the 60-60G and 84-98 regions were observed to interact with the N-glycan in the glycosylated fIIa system (Supplementary data, Table S1 ). Hence, their decreased motions in glycosylated systems may be attributed to their direct interaction with the Asn60G-linked oligosaccharide. In addition, from a dynamic network analysis (Supplementary data, Tables S2 and 3), it was observed that most residues comprising regions 84-98 ( Figure 1D , region 2) and 165-180 ( Figure 1D , region 4) are within the same community during all thrombin simulations, which indicates that their movement is correlated. Such data were confirmed by principal component analysis (PCA) on the MD trajectories, in which such regions showed decreased motions in the principal component of the flexibility of glycosylated thrombin (Supplementary data, Figure S2E ). In this context, while region 4 has no interaction with fIIa N-glycan, and showed a different interaction pattern with the solvent, its decreased flexibility may be associated with region 2 reduced motions.
Serine proteases-heparin binding. Heparin binding to the studied serine proteases was initially evaluated by the energy interaction profile between such a polysaccharide and basic residues in the proteinases surface (Table II) . For this comparison, the amino acid residues previously identified, through site-directed mutagenesis, as important components of exosite 2 of both fIIa and fXa (Sheehan and Sadler 1994; Rezaie 2000) , were considered. Based on such analysis, it was observed that the amino acid residues showing more intense interaction energies with heparin are indeed those previously recognized as important for exosite 2-GAG recognition, mainly Arg93, L Pol-Fachin and H Verli Arg126, Lys236 and Arg240 (Sheehan and Sadler 1994; Rezaie 2000) . Markedly, Arg165 and Lys169, identified as exosite 2-composing residues in fXa (Rezaie 2000) , strongly interacted with the polysaccharide in the fXa-heparin system, while their counterparts in thrombin, Arg165 and Arg169, not identified as components of fIIa exosite 2, presented no interaction with the GAG (Table II) . Such a behavior is also observed for fIIa Arg233 and Lys235 positively charged amino acid residues, described to compose thrombin exosite 2 (Sheehan and Sadler 1994) , which interact with heparin during simulations, and their counterparts in fXa, Ala233 and Leu235, which showed no significant interaction with the GAG (Table II) . Moreover, frames were collected at every 10 ns of the entire 0.1 μs trajectories, from which the heparin orientation in relation to the serine proteases was assessed (Figure 2A-D) . As a general feature, during MD simulations, the oligosaccharides indeed remained around the proteases exosite-2 (Figure 2A-D) , resembling the fIIa-heparin orientation ( Figure 2E ) in the X-ray structure of their ternary complex with AT (Li et al. 2004 ). However, in non-glycosylated thrombin ( Figure 2A ) and fXa with Ca 2+ ( Figure 2D ) systems, heparin orientation showed an increased fluctuation on the surface of the enzymes when compared with glycosylated thrombin ( Figure 2B ) and fXa in the system without Ca 2+ ( Figure 2C ). Moreover, the interaction energy between heparin and exosite-2 composing residues was higher in these systems in which the oligosaccharide presented reduced fluctuations (Table II) . Furthermore, in contrast to what The active site pocket volume was measured and averaged, with ±standard deviation, from frames collected at every 10 ns of MD simulations. All evaluated residues −518 ± 101 −579 ± 97 −580 ± 96 −395 ± 117
Underlined residues were previously identified as important for the enzymes interaction with heparin. a
The entire employed timescale (0.1 μs) was considered for obtaining the average and standard deviation values.
Heparin dynamics on the surface of thrombin and fXa happened due to glycosylation, heparin binding to fIIa appeared to promote a flexibility increase in the 60-60G, 84-98, 140-150 and 165-180 regions that encircle the thrombin active site ( Figure 2F -G). Regarding fXa, no major flexibility differences may be observed due to heparin binding, but a decreased motion around residue 60 ( Figure 2I and J), in a region that directly interacts with heparin during simulations. The only exception is the 120-134 region of fXa system without Ca 2+ ( Figure 2I ), consisting of a helix that unfolded in the trajectory without heparin. Still, the flexibility behavior of both proteases is in agreement with a B-factor profile obtained by averaging their per residue values in more than 200 PDB entries for fIIa ( Figure 2H , in comparison with Figure 2F and G) and in approximately 80 PDB entries for fXa ( Figure 2K , in comparison with Figure 2I and J). In addition, the RMSD associated with such domains reflect the stability achieved during the second half of the simulations (Supplementary data, Figure S2 ), considered for the RMSF analyses.
Active site environment. Based on fluorescence evidences that the interaction of GAGs to fIIa and fXa exosites-2 induce conformational changes to their active sites (Fredenburgh et al. 1997; O'Brien et al. 2003) , and in order to explore the effects of heparin binding on the serine proteases, the environment around the catalytic triad (His57, Asp102 and Ser195) of such enzymes was evaluated (Figure 3) . From dynamic network analyses performed on the trajectories (Supplementary data, Table S2 and S3), it was observed that His57 and Asp102 were always within the same community, which reflects that their backbone movements were correlated in spite of heparin binding to either fIIa or fXa. On the other hand, His57 and Asp102 side-chain conformations were observed to be modified in previous publications due to inhibitors binding to fIIa exosite 2 (Fernández et al. 2013) . Accordingly, in the present work, we observed that the hydrogen bond interaction between His57 Nδ1 and Asp102 Oδ2 was partially disrupted due to a strong heparin binding to the enzymes exosite-2-composing residues ( Figure 3C and D) , that is, in glycosylated fIIa and fXa in the system without Ca 2+ (Table II) . As a consequence of this binding, the distance between His57 Nδ1 and Asp102 Oδ2, which predominantly showed distances compatible with a hydrogen bond in the absence of heparin ( 3 Å), presented a new conformational state when complexed to the GAG ( 5 Å), thus departing such residues ( Figure 3A) and partially disrupting the catalytic triad organization. Such increase in the distance between His57 Nδ1 and Asp102 Oδ2 was accompanied by modifications in His57 rotameric state (Hansen and Kay 2011) . In the system containing heparin-unbound fXa in the absence of Ca 2+ , His57 mostly populated the gauche+ (χ 1 = 60 degrees) state, and in glycosylated fIIa both gauche+ and trans (χ 1 = 180 degrees) states (Supplementary data, Figure S3 ). In the presence of heparin, in the two systems in which the catalytic triad organization was disturbed, His57 showed as equilibrium between the three possible rotameric states (Supplementary data, Figure S3 ), including a high prevalence of the gauche- , on the other hand, heparin interaction with the enzymes exosite 2-composing residues was weaker (Table II) . Accordingly, the GAG also appeared to act modulating the distance between His57 Nδ1 and Asp102 Oδ2, so that the 5 Å conformation was not observed ( Figure 3B and E) and His57 rotameric state remained unaltered, as in the case of fXa, or was stabilized in the gauche+ state, in non-glycosylated thrombin (Supplementary data, Figure S3 ).
Insights into heparin mechanisms of action
Extrapolating the obtained results in the context of AT-proteases-GAG ternary complexes, the orientation of heparin on the surface of the physiologically occurring, glycosylated fIIa, but not fXa-neither in the presence nor in the absence of Ca 2+ -would allow a linear long-chain heparin binding to AT considering the bridge (template) mechanism (Figure 2A -E, shaded arrows). Such assumption is in accordance with previous suggestions based on the AT-fXa complex, in which it was proposed that a direct linear heparin bridge is not possible (Johnson et al. 2006) . Therefore, it may be suggested that fXa is less susceptible to the bridge mechanism since its preferred orientation in relation to AT, as observed in previous X-ray structures (Johnson et al. 2006) , does not allow the GAG to assume the linear conformation expected for such polysaccharide (Mulloy et al. 1993 ). Thus, heparin, in AT-fXa-GAG bridge complexes should bend perpendicularly on the surface of fXa in comparison with its observed orientation in previous X-ray studies for the AT-fIIa complex (Li et al. 2004 ). It may be observed, however, that the GAG orientation on the surface of fXa in the system with Ca 2+ was more related to the available fIIa-heparin-AT ternary complex structure than in the absence of such a cation ( Figure 2C -E, shaded arrows). In this context, it may be proposed that Ca 2+ approaches heparin orientation on the surface of fXa to a linear long-chain GAG binding with AT. Such heparin reorientation appeared to be mediated by an intense Ca 2+ interaction with the heparin region responsible for the main contacts between fXa exosite 2-composing residues and the GAG (Supplementary data, Table S4 and Figure S4 ). Regarding thrombin, heparin dynamics on the surface of glycosylated fIIa most perfectly fitted the required GAG arrangement in an AT-proteases-heparin ternary complex, while in non-glycosylated fIIa, it was quite comparable to its behavior when bound to fXa in the system with Ca 2+ . Thus, it may be proposed that thrombin glycosylation, present in the physiologically occurring form of the enzyme, facilitates a proper AT-fIIa-heparin complex formation.
Discussion
While little is known about the effects of glycosylation on thrombin (Nilsson et al. 1983; Rosenfeld and Danishefsky 1984) , the presence of N-glycans has been related to influence a broad range of properties from other glycoproteins, such as structure, folding and function (Pol-Fachin and Verli 2011). Still, conformational stabilization is the property reported to be most frequently modified by glycosylation (Pol-Fachin and Verli 2011). Accordingly, insights into the molecular basis for the flexibility decrease of the regions 60-60G, 84-98 and 165-180, caused by glycosylation, could be suggested in the present study. However, those related to the flexibility difference of 140-150 residues could be not proposed, as such loop had no interaction with thrombin N-glycan, and was separated in different communities to those of the remaining evaluated regions, as observed from dynamic network analyses, and confirmed by PCA. Still, based on the results obtained in the present work, it may be proposed that glycosylation shows a conformational Figure 3 . Catalytic triad arrangement in the studied enzymes. In (A), the different conformational states of the enzymes active site are presented (exemplified with thrombin, which structure is shown in ribbon diagrams and catalytic triad amino acid residues as sticks). In (B-E), the distances between the Nδ1 atom of His57 and Oδ1 atom of Asp102, which perform a hydrogen bond within the enzymes catalytic triad, are presented in their unbound (gray) and heparin-bound (coloured, online; foreground graphs in print) states.
Heparin dynamics on the surface of thrombin and fXa stabilization effect on fIIa, by decreasing the mobility of the above-mentioned regions, around the enzyme active site.
Heparin is recognized to be mostly involved with a serpinmediated thrombin inhibition (Olson et al. 2004) , and presumably does not alter such enzyme catalytic activity (Henry et al. 2007 ) while interacting with its exosite 2. Still, based on fluorescence data, conformational changes on fIIa and fXa active sites could be proposed due to GAGs binding to the enzymes surface (Fredenburgh et al. 1997; O'Brien et al. 2003) . In this context, a partial disruption of such proteases catalytic triad could be observed due to a strong heparin binding to such enzymes exosites 2 (Figure 3) , which may be proposed as the conformational changes observed in fluorescence experiments. Moreover, heparin binding was observed to additionally increase the flexibility of [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] and to decrease its active site pocket size (Table I) . Such aspects, which are possibly not related to thrombin direct inhibition by heparin, may indeed contribute to its inhibition by AT-GAG complexes, in which fIIa demands an interaction with the polysaccharide. In this context, the conformational modulation observed in the present work in regions that encircle thrombin active site are reinforced by findings that 140-150 and 165-180 loops were also observed to show an increased mobility when thrombin is inhibited by PPACK (Fuglestad et al. 2012) . Also, no analogous regions exist in fXa, and thus, only the disruption of His Nδ1 to Asp Oδ2 distance occurs. Therefore, the observed influence of heparin binding on those regions encircling thrombin active site may also contribute to the higher antithrombin-heparin complex inhibition constant over fIIa than fXa (Craig et al. 1989) .
Finally, the orientation of heparin on the surface of the evaluated serine proteases could be correlated with their diverse susceptibilities to heparin mechanisms of action. In fact, the orientation of heparin on the surface of fXa, in the absence of Ca 2+ , would not allow a long linear arrangement of the GAG in a ternary complex with AT, which may contribute to its higher susceptibility to the conformational change-based mechanism, in which heparin does not directly interact with fXa. Markedly, considering previous studies indicating that fXa is only capable of forming a bridging complex with heparin in the presence of Ca 2+ (Rezaie 1998; Rezaie and Olson 2000) , the presence of this cation maintained heparin orientation on the surface of fXa similar to that observed for non-glycosylated fIIa, thus closer to the linear arrangement for a long-chain heparin binding to AT. Additionally, in the presence of glycosylation, thrombin interacted more intensely with the GAG, and its orientation on the surface of the enzyme mostly superimposed the required heparin arrangement in ternary complexes. Such data are expected to support future studies of the development of new anticoagulant agents, mimicking heparin interactions, both on AT and serine proteases, or focused on the enzymes exosite 2.
Materials and methods
Nomenclature and software
The recommendations and symbols of nomenclature as proposed by IUPAC (IUPAC 1996) are used. All saccharide topologies were generated with the PRODRG server (Schuettelkopf and van Aalten 2004) , the manipulation of structures was performed with MOLDEN (Schaftenaar and Noordik 2000) , VMD (Humphrey et al. 1996) and PyMOL (The PyMOL Molecular Graphics System), the homology modeling was performed with MODELLER v9.8 (Sanchez et al. 2000) , the dynamic network analysis was performed with NetworkView (Eargle and Luthey-Schulten 2012) extension of VMD and all MD calculations and remaining analyses were performed using the GROMACS simulation suite (van der Spoel et al. 2005 ) and the GROMOS96 43A1 force field (Scott et al. 1999) .
Topology construction for non-usual amino acid and carbohydrate residues The employed protocol for carbohydrate topology construction was based on previous studies, for both N-glycan structures (Pol-Fachin et al. 2009 and sulfated polysaccharides Guimarães 2004, 2005; Pol-Fachin and Verli 2008; Fernández et al. 2013 ). Such parameters, based on the GROMOS 43A1 force field, have been extensively validated against X-ray crystallography and NMR data, which substantiate the use of these topologies for carbohydrate MD simulations. Specifically, the monosaccharide fragments composing thrombin N-glycan chain and heparin polysaccharide fragments were constructed using the MOLDEN software (Schaftenaar and Noordik 2000) . Each structure was then submitted to the PRODRG server (Schuettelkopf and van Aalten 2004) , from which the crude topologies were retrieved. Based on such information, these structures were described in GROMOS96 43A1 force field parameters and further refined through: (1) C 5 (NeuAc) forms; (2) proper dihedrals, as described in the GROMOS96 43a1 force field for glucose, in order to support stable simulations (Pol-Fachin et al. 2009 ) and (3) Löwdin HF/6-31G**-derived atomic charges, obtained from previous works of the group (Verli and Guimarães 2004; Pol-Fachin et al. 2009 ). In addition, the post-translational modifications known to occur along fXa light-chain polypeptide structure were also considered, that is, the presence of GLA residues at the GLA-domain and β-hydroxyaspartate (BHD) at position 63 (Hansson and Stenflo 2005) . Thus, the parameters for such non-usual amino acid residues were compiled based on groups present within the GROMOS96 43A1 force field: the carboxylate group was used to build GLA from Glu residues, and the additional hydroxyl group of BHD was parameterized based on Ser side chain.
Thrombin N-glycosylation. The non-glycosylated thrombin protein core, comprising its complete light-and heavy-chain sequences, was retrieved from PDB ID 1PPB (Bode et al. 1989) . In order to generate an initial model for its glycosylated, physiologically occurring form, the N-glycosylation site, located at the heavy-chain Asn60G (according to chymotrypsin numbering) residue, was modified to include a complex type, biantennary glycan structure, with two terminal sialic acids ( Figure 1A ), proposed as thrombin oligosaccharide moiety (Nilsson et al. 1983 ), using glycosciences modeling tools (Lütteke et al. 2006) . Such models had their glycosidic linkage geometries adjusted to the main conformational states for each linkage, based on their relative abundance in the isolated L Pol-Fachin and H Verli disaccharides in water, as previously described (Fernandes et al., 2010; .
fXa light-chain homology modeling. While the 3D structure for fXa heavy chain was retrieved from PDB ID 1XKA (Kamata et al. 1998) , comprising its complete polypeptide sequence, a model for complete fXa light chain was performed using homology modeling techniques, employing MODELLER9v8 (Sanchez et al. 2000) , as previously described (Mulinari et al. 2011) . The modeling was carried out by combining templates from PDB ID 1WHE (Sunnerhagen et al. 1996) for residues 1-53 and from PDB ID 1XKA (Kamata et al. 1998 ) for 54-139. The selection and validation of the best model, from fifty constructed structures, was based on stereochemical evaluation with PROCHECK (Laskowski et al. 1993) , while additional validations with Verify3D (Lüthy et al. 1992 ) and QMEAN6 (Benkert et al. 2011) in the "Structure Assessment" tool of SwissModel (Arnold et al. 2006) were also employed (Supplementary note 1; Supplementary data, Figure S5 ). The complete fXa structure was then obtained by superimposing the obtained model for fXa light chain (residues 1-139) to that previously contained within PDB ID 1XKA (residues 54-139).
Building the initial models for heparin-proteases complexes. A heparin fragment containing 10 carbohydrate residues was built based on the most prevalent geometries obtained from solution MD simulations of heparin-composing disaccharides (Supple-mentary data, Figure S6A ), as previously determined (Pol-Fachin and Verli 2008; . Such polysaccharide sequence was constructed aiming to mimic the known monosaccharide proportions in the regions involved with AT binding to heparin (Guerrini et al. 2008) as, in ternary complexes involving the studied enzymes and AT, the constructed heparin sequence would be vicinal to the GAG region interacting with the serpin. Subsequently, such a heparin molecule was complexed to both fIIa and fXa through superimposition to the oligosaccharide orientation as observed in PDB ID 1TB6 (Li et al. 2004) . Modeling the fXa-GAG complex based on the structure within PDB ID 2GD4 (Johnson et al. 2006) , which contains an AT-fXa-pentasacharide complex, was not possible (1) as no direct fXa-heparin interaction is observed in such a structure and (2) because, while superimposing a long-chain heparin to the pentasaccharide, the GAG portion near the enzyme remained away from fXa exosite 2. The obtained complexes fulfill heparin orientation on the surface of thrombin (Supplementary data, Figure S6 ), as observed on previous X-ray crystallography studies (Li et al. 2004; Carter et al. 2005) . The validation of heparin dynamics during MD was performed by comparing the GAG glycosidic linkages conformation with NMR-derived models (Mulloy et al. 1993 ), X-ray structures (Khan et al. 2010 ) and a free heparin MD simulation (Supplementary note 2; Supple-mentary data, Table S5 ).
MD simulations
Each non-glycosylated and glycosylated thrombin structure, as well as the modeled fXa in the presence and absence of Ca 2+ ions, was generated either in an uncomplexed or in a heparincomplexed state. Globally, eight systems were simulated up to 0.1 μs: (1) non-glycosylated thrombin, heparin-absent, (2) glycosylated thrombin, heparin-absent, (3) non-glycosylated thrombin, complexed to heparin, (4) glycosylated thrombin, complexed to heparin, (5) fXa, heparin-absent, system without Ca 2+ ions, (6) fXa, heparin-absent, system with Ca 2+ ions, (7) fXa, complexed to heparin, system without Ca 2+ ions, and (8) fXa, complexed to heparin, system with Ca 2+ ions. Additionally, a ninth system, comprising a free 0.1 μs heparin MD simulation, was also performed for reference. Such structures were solvated in triclinic boxes using periodic boundary conditions and SPC water model (Berendsen et al. 1987) , employing a 10 Å distance from the outside of each structure and the box edge. In the systems in which the presence Ca 2+ was considered, such divalent cation was added in its known physiological concentration. After that, in order to neutralize the charge of the eight simulated systems, which were highly negative, due to heparin sulfate and sulfonamide groups, counter ions (Na + or Cl − ) were added. The MD protocol, including general simulation parameters and thermalization procedures, was employed on previous studies, as described for other heparin-protein complexes (Verli and Guimarães 2005; . The Lincs method (Hess et al. 1997 ) was applied to constrain covalent bond lengths, allowing an integration step of 2 fs after an initial energy minimization using Steepest Descents algorithm. Electrostatic interactions were calculated through the Particle Mesh Ewald method (Darden et al. 1993) . Temperature and pressure were kept constant by coupling (glyco)proteins, heparin, ions and solvent to external temperature and pressure baths with coupling constants of τ = 0.1 and 0.5 ps (Berendsen et al. 1984) , respectively. The systems were heated slowly from 50 to 310 K, in steps of 5 ps, each one increasing the reference temperature by 50 K. In the case of proteases-heparin complexes, before data collection, 10 ns MD simulations were also employed as equilibration steps, as previously described . After this heating/equilibration, all simulations were further simulated to 0.1 μs under a constant temperature of 310 K.
Dynamic network analysis
The general idea of a dynamic network analysis is to assess interaction networks within a system, usually assuming that each amino acid residue is a node, and the contacts between them are represented by links (Sethi et al. 2009 ). In this context, a weight is given to those connections, depending on the intensity of these interactions. Of interest to the present work, a community of amino acids is established when the nodes representing the amino acid residues within that group have a higher number or stronger links to each other. Such concept can be compared to a structural domain in a polypeptide (Eargle and Luthey-Schulten 2012) , but here it is defined by the protein dynamics, and not by its tertiary structure.
Supplementary data
Supplementary data for this article are available online at http:// glycob.oxfordjournals.org/.
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